What is the typical duration a double J (double J ureteral stent) is left in place after placement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Double J ureteral stents are typically left in place for 2-6 weeks, with the most common duration being 4 weeks, as determined by the urologist based on the patient's specific condition, the complexity of the procedure, and healing requirements. The exact timing depends on the reason for stent placement, with stents usually kept for 1-2 weeks after urinary stone removal, 2-4 weeks following ureteroscopy or other urological procedures, and 4-6 weeks for stents placed during kidney transplantation. For patients with chronic conditions requiring long-term stenting, the stents need replacement every 3-6 months to prevent encrustation and infection, as supported by studies such as 1.

Some key considerations for the duration of double J stent placement include:

  • The type of procedure performed, with ureteroscopy and other urological procedures often requiring longer stent placement durations 2
  • The presence of complications, such as impacted stones or intraoperative complications, which may require longer stent placement durations 2
  • The patient's overall health and medical history, including the presence of a solitary kidney or preoperative stent placement, which may influence the decision to place a stent and the duration of placement 2
  • The risk of stent-related symptoms, such as urinary frequency, urgency, and flank discomfort, which can be mitigated with medications such as Tolterodine, as shown in studies such as 3

It's essential for patients to follow up with their urologist for stent removal as scheduled, as forgotten stents can lead to serious complications, including infection, stone formation on the stent, and kidney damage. The use of alternative stent types, such as pigtail suture stents, may also reduce stent-related symptoms, as demonstrated in studies such as 4. Ultimately, the decision on the duration of double J stent placement should be individualized based on the patient's specific needs and medical history, with the goal of minimizing morbidity, mortality, and improving quality of life.

Related Questions

What is the management and rationale for using a JJ (Double J) stent in patients with kidney stones?
Do patients require Tamsulosin (alpha-blocker) after double J (Double J ureteral stent) placement?
What is the procedure for reinserting a double J (double pigtail) stent after it has fallen out?
Is a stent typically placed after ureteral stone removal?
What is the procedure and management for Double J (DJ) stenting in patients with ureteral obstruction?
What are the typical ECG (electrocardiogram) findings in patients with hypertrophic cardiomyopathy (HCM)?
What is the normal respiratory rate (RR) for a 17-month-old child?
Can amiodarone be administered to a patient with atrial fibrillation (AF) who is hypotensive but has an uncontrolled ventricular response, and when should vasopressor support be initiated?
What is the initial management approach for patients with cardiomyopathy presenting with ST elevation?
What is the next step in managing an 80-year-old female patient with bacteremia and osteomyelitis, who has wide complex tachycardia, occasional premature ventricular contractions (PVCs), and nonsustained ventricular tachycardia (VT), currently on amiodarone and metoprolol, with a left ventricular (LV) ejection fraction of 71% and mild mitral annular calcification?
Can a person with a history of hepatitis B (HB) infection, who is hepatitis B core (HBc) antibody positive, hepatitis B virus (HBV) deoxyribonucleic acid (DNA) negative, and hepatitis B surface antigen (HBsAg) negative, be a stem cell donor?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.